IL197189A0 - Methods of lowering glucose levels - Google Patents

Methods of lowering glucose levels

Info

Publication number
IL197189A0
IL197189A0 IL197189A IL19718909A IL197189A0 IL 197189 A0 IL197189 A0 IL 197189A0 IL 197189 A IL197189 A IL 197189A IL 19718909 A IL19718909 A IL 19718909A IL 197189 A0 IL197189 A0 IL 197189A0
Authority
IL
Israel
Prior art keywords
methods
glucose levels
lowering glucose
lowering
levels
Prior art date
Application number
IL197189A
Other languages
English (en)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of IL197189A0 publication Critical patent/IL197189A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
IL197189A 2006-08-28 2009-02-23 Methods of lowering glucose levels IL197189A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84085006P 2006-08-28 2006-08-28
PCT/EP2007/007160 WO2008025450A1 (en) 2006-08-28 2007-08-14 Methods of lowering glucose levels

Publications (1)

Publication Number Publication Date
IL197189A0 true IL197189A0 (en) 2009-12-24

Family

ID=38578487

Family Applications (1)

Application Number Title Priority Date Filing Date
IL197189A IL197189A0 (en) 2006-08-28 2009-02-23 Methods of lowering glucose levels

Country Status (12)

Country Link
US (1) US20080188538A1 (enExample)
EP (1) EP2059242A1 (enExample)
JP (1) JP2010501604A (enExample)
KR (1) KR20090042976A (enExample)
CN (1) CN101573110A (enExample)
AU (1) AU2007291602B2 (enExample)
BR (1) BRPI0716411A2 (enExample)
CA (1) CA2661598A1 (enExample)
IL (1) IL197189A0 (enExample)
MX (1) MX2009002091A (enExample)
NO (1) NO20090926L (enExample)
WO (1) WO2008025450A1 (enExample)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
DE3226768A1 (de) * 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
DE3413710A1 (de) * 1984-04-12 1985-10-24 Hoechst Ag, 6230 Frankfurt Verfahren zur behandlung der herzinsuffizienz
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
CA2026686A1 (en) * 1989-10-30 1991-05-01 Werner Tschollar Method for preventing onset of type ii diabetes employing an ace inhibitor
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
DK1216038T3 (da) * 1999-08-30 2005-12-27 Sanofi Aventis Deutschland Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser
WO2003032965A2 (en) * 2001-10-17 2003-04-24 King Pharmaceuticals Research And Development, Inc Use of ace inhibitors for reducing type 2 diabetes in high risk patients
US20050065203A1 (en) * 2001-10-17 2005-03-24 Salim Yusuf Method of reducing type 2 diabetes in high risk patients
CA2458288A1 (en) * 2003-03-11 2004-09-11 Institut De Cardiologie De Montreal / Montreal Heart Institute Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure

Also Published As

Publication number Publication date
JP2010501604A (ja) 2010-01-21
AU2007291602A1 (en) 2008-03-06
CA2661598A1 (en) 2008-03-06
AU2007291602B2 (en) 2012-09-06
US20080188538A1 (en) 2008-08-07
MX2009002091A (es) 2009-03-09
EP2059242A1 (en) 2009-05-20
CN101573110A (zh) 2009-11-04
KR20090042976A (ko) 2009-05-04
WO2008025450A1 (en) 2008-03-06
NO20090926L (no) 2009-03-27
BRPI0716411A2 (pt) 2013-09-24

Similar Documents

Publication Publication Date Title
HRP20180611T1 (hr) Postupci smanjenja razina bazofila
ZA200805297B (en) Method of using ß-hydroxy-ß-methylbutyrate
ZA201002696B (en) Methods of maintaining or increasing growth or cognitive development
EP2032131A4 (en) Methods of Treatment
IL185757A0 (en) Methods of decreasing calcifcation
EP2082062A4 (en) EXPERIENCE FOR ALLELY TYPING
IL192319A0 (en) Assessment of medical conditions
GB0705854D0 (en) Methods of construction
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
GB0605360D0 (en) Method of manufacture
ZA200903408B (en) Methods of providing long-term nutrition
EP2067606A4 (en) PHOTO PROCESS
GB0610746D0 (en) Method of treatment
ZA200900638B (en) Method of diagnosis
EP1919477A4 (en) METHOD FOR IMPROVING THE GRID OF GROWTH
ZA200900639B (en) Method of diagnosis
GB2443299B (en) Method of monodiameter well construction
PL1934388T3 (pl) Sposób projektowania leków
ZA200800590B (en) Method of improving wakefulness
IL178683A0 (en) Methods of diminishing co-abuse potenitial
TWM311768U (en) Improved structure of A-ladder
GB0613968D0 (en) Method of determination
GB2452842B (en) Method of increasing activity
IL178172A0 (en) Method of organism rejuvenation
TWM300223U (en) Improved structure of drain